Skip to Content

Demant A/S

DEMANT: XCSE (DNK)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
DKK 472.00QxzyffnMcbshlhr

Demant Sees Strong Recovery in Hearing but Continuing Weakness in Communications

Business Strategy and Outlook

Demant benefits from favourable trends, including an ageing population, increasing noise pollution, fairly low penetration rates in the developed world, and virtually untapped patient populations in emerging markets such as China where Demant acquired the retail chain ShengWang in June 2022. Demant's broad product offerings should allow the company to capitalize on these trends, while its strong brand and superior technological know-how should yield market share gains. After selling its implant business, Demant is in a better position to focus its efforts and maintain its top-tier positioning in the market.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of DEMANT so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center